- Issue: Improper off-label use
Lieff Cabraser represents patients who have suffered serious injuries from the off-label use of the Infuse bone graft, manufactured by Medtronic Inc. The Food and Drug Administration has approved Infuse for only one type of spine surgery, the anterior lumbar fusion. Many patients, however, received an off-label use of Infuse were never informed of the off-label nature of the surgery. Serious complications associated with Infuse include uncontrolled bone growth and chronic pain from nerve injuries.